MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Biomaterials (Orthopedic: Synthetic Bone, Cartilage & Skin Substitutes)
Histogenics Corporation (Nasdaq: HSGX)
Organization & Developments: Histogenics
Parents
Histogenics Corporation (Nasdaq: HSGX)
Children
2011: Histogenics has one product, an autologous knee cartilage regeneration system called NeoCart, in a pivotal Phase III trial (2011).
2011: ProChon's BioCart product, which uses a proprietary growth factor with a biocompatible scaffold for knee cartilage repair, is in a Phase II trial (2011)
Focus is on repairing articular cartilage damage utilizing advancements in cell biology, tissue culture, engineering, and materi
Jumps
*Key People: Histogenics
Finance & Acquisitions: Histogenics